Cargando…
High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme
BACKGROUND: Population-based screening for atrial fibrillation (AF) is a promising public health strategy to prevent stroke. However, none of the published reports have evaluated comprehensive screening for additional stroke risk factors such as hypertension and diabetes in a pharmacy setting. METHO...
Autores principales: | Sandhu, Roopinder K, Dolovich, Lisa, Deif, Bishoy, Barake, Walid, Agarwal, Gina, Grinvalds, Alex, Lim, Ting, Quinn, F Russell, Gladstone, David, Conen, David, Connolly, Stuart J, Healey, Jeff S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237744/ https://www.ncbi.nlm.nih.gov/pubmed/28123758 http://dx.doi.org/10.1136/openhrt-2016-000515 |
Ejemplares similares
-
Modifiable risk factors predict incident atrial fibrillation and heart failure
por: Wong, Jorge A, et al.
Publicado: (2020) -
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
por: Sandhu, Roopinder K, et al.
Publicado: (2018) -
Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022) -
Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
por: Moschovitis, Giorgio, et al.
Publicado: (2021) -
Efficacy and safety of dabigatran versus warfarin from the RE-LY trial
por: Avezum, Alvaro, et al.
Publicado: (2018)